Correction to: Validation of a nuclear grading system for resected stage I–IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial

Breast Cancer - Tập 29 Số 4 - Trang 730-730 - 2022
Hitoshi Tsuda1, Masafumi Kurosumi2, Futoshi Akiyama3, Shinji Ohno4, Shigehira Saji5, Norikazu Masuda6, Akihiko Shimomura7, Nobuaki Sato8, Shintaro Takao9, Shozo Ohsumi10, Yutaka Tokuda11, Hideo Inaji12, Toru Watanabe13
1National Defense Medical College. Saitama, Japan
2Kameda Medical Center, Chiba, Japan
3Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan
4Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan
5Fukushima Medical University, Fukushima, Japan
6Nagoya University Graduate School of Medicine, Nagoya, Japan
7National Cancer Center Hospital, Tokyo, Japan
8Niigata Cancer Center Hospital, Niigata, Japan
9Hyogo Cancer Center, Hyogo, Japan
10NHO Shikoku Cancer Center, Ehime, Japan
11Tokai University School of Medicine, Kanagawa, Japan
12Kaizuka City Hospital, Osaka, Japan
13Hamamatsu Oncology Center, Shizuoka, Japan

Tóm tắt

Từ khóa


Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Breast Cancer

Tập 29 Số 4

730-730

Thông tin tác giả